Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents

NCT01414933 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT01414933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01414933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents
Lead sponsor
UNICANCER
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
May 31, 2013
Enrollment
423 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer